Three years after becoming the first subject in a CGD gene therapy trial at @ChildCancerCare, Brendan Whittaker is planning for a future he never thought he’d havehttps://news.harvard.edu/gazette/story/2019/02/three-years-after-undergoing-gene-therapy-his-last-shot-hit-the-target/ …
0 replies
27 retweets
79 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.